AMC practice

Women’s health

Partner considerations

A 26-year-old woman attends a Melbourne sexual health clinic with her regular female partner. She has had 1 week of malodorous thin grey vaginal discharge, and a copper IUD was inserted 2 months ago. She is afebrile, BP 116/74 mmHg, HR 76/min, with no pelvic tenderness. Speculum examination shows homogeneous discharge, vaginal pH 5.7, a positive whiff test and clue cells on Gram stain. Chlamydia and gonorrhoea NAATs are pending. She has no allergies. Her partner has had intermittent odour but has not been assessed, and the patient wants to reduce her risk of recurrence. What is the best management plan?

  1. Clindamycin 2% vaginal cream nocte for 7 days for her; no partner testing or treatment
  2. Metronidazole 2 g orally stat for her; offer her partner BV testing and treat if positive
  3. Metronidazole 400 mg orally BD for 7 days for her; oral metronidazole with penile clindamycin cream for her partner
  4. Metronidazole 400 mg orally BD for 7 days for her; offer her partner BV testing and treat if positive
  5. Metronidazole 400 mg orally BD for 7 days for her; empirical oral metronidazole for her partner without testing
Answer this question